In summary, we successfully prepared a novel type of cancer-targeting functionalized G4/MTX-siRNA nanocomplex for the efficient delivery of MTX and anti- HMGA2 siRNA to target and treat folate expressing human breast cancer (MCF-7 and MDA-MB-231) cells. Here, HMGA2 is linked to breast carcinoma.